Trials / Completed
CompletedNCT00405964
Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)
Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter/Multinational, Efficacy and Safety Study of Desloratadine 5 mg in the Treatment of Subjects With Allergic Rhinitis Who Meet the Criteria for Persistent Allergic Rhinitis (PER)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 716 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the effectiveness of desloratadine in treating subjects with allergic rhinitis who meet the criteria for persistent allergic rhinitis (PER)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5-mg Desloratadine | 5-mg Desloratadine tablet, once daily for 12 weeks |
| DRUG | Placebo tablet | Placebo tablet, once daily for 12 weeks |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2006-12-04
- Last updated
- 2024-05-20
- Results posted
- 2010-11-19
Source: ClinicalTrials.gov record NCT00405964. Inclusion in this directory is not an endorsement.